Detailed information for compound 411697

Basic information

Technical information
  • TDR Targets ID: 411697
  • Name: 2-(4-fluorophenyl)-3-hydroxy-7,8-dimethylquin oline-4-carboxylic acid
  • MW: 311.307 | Formula: C18H14FNO3
  • H donors: 2 H acceptors: 4 LogP: 4.4 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: Fc1ccc(cc1)c1nc2c(C)c(C)ccc2c(c1O)C(=O)O
  • InChi: 1S/C18H14FNO3/c1-9-3-8-13-14(18(22)23)17(21)16(20-15(13)10(9)2)11-4-6-12(19)7-5-11/h3-8,21H,1-2H3,(H,22,23)
  • InChiKey: SOPKKIOSDFWWAD-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 2-(4-fluorophenyl)-3-hydroxy-7,8-dimethyl-quinoline-4-carboxylic acid
  • 2-(4-fluorophenyl)-3-hydroxy-7,8-dimethyl-4-quinolinecarboxylic acid
  • 2-(4-fluorophenyl)-3-hydroxy-7,8-dimethyl-cinchoninic acid

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trypanosoma cruzi mitochondrial DNA polymerase beta, putative 0.1212 1 1
Loa Loa (eye worm) hypothetical protein 0.0302 0.1259 0.5
Echinococcus granulosus ATP dependent DNA helicase PIF1 0.0482 0.2996 1
Trypanosoma cruzi mitochondrial DNA polymerase beta, putative 0.1212 1 1
Trypanosoma brucei DNA repair and recombination helicase protein PIF7 0.0482 0.2996 0.2996
Entamoeba histolytica hypothetical protein, conserved 0.0482 0.2996 0.5
Trypanosoma brucei mitochondrial DNA polymerase beta-PAK 0.0574 0.3871 0.3871
Brugia malayi DNA polymerase alpha catalytic subunit 0.0178 0.0072 0.5
Trypanosoma cruzi DNA repair and recombination helicase protein PIF6, putative 0.0482 0.2996 0.2996
Trypanosoma cruzi DNA repair and recombination helicase protein PIF7, putative 0.0482 0.2996 0.2996
Plasmodium vivax DNA polymerase alpha, putative 0.0178 0.0072 0.5
Echinococcus multilocularis ATP dependent DNA helicase PIF1 0.0482 0.2996 1
Trichomonas vaginalis conserved hypothetical protein 0.0482 0.2996 0.5
Leishmania major mitochondrial DNA polymerase beta-PAK, putative 0.0574 0.3871 0.125
Trypanosoma cruzi DNA repair and recombination helicase protein PIF7, putative 0.0482 0.2996 0.2996
Giardia lamblia Rrm3p helicase 0.0482 0.2996 1
Mycobacterium tuberculosis Conserved hypothetical protein 0.0638 0.4493 0.5
Mycobacterium ulcerans hypothetical protein 0.0638 0.4493 0.5
Trypanosoma brucei DNA repair and recombination helicase protein PIF6 0.0482 0.2996 0.2996
Entamoeba histolytica DNA repair and recombination protein, putative 0.0482 0.2996 0.5
Trypanosoma cruzi mitochondrial DNA polymerase beta-PAK, putative 0.0574 0.3871 0.3871
Toxoplasma gondii hypothetical protein 0.0195 0.0241 1
Trypanosoma brucei mitochondrial DNA polymerase beta 0.1212 1 1
Schistosoma mansoni hypothetical protein 0.0482 0.2996 1
Trypanosoma cruzi mitochondrial DNA polymerase beta-PAK, putative 0.0208 0.0358 0.0358
Onchocerca volvulus DNA polymerase alpha catalytic subunit homolog 0.0302 0.1259 0.5

Activities

Activity type Activity value Assay description Source Reference
Inhibition (binding) = 43 % Inhibition of human recombinant P-selectin expressed in CHO cells by Biacore assay at 1 mM ChEMBL. 17201408
Inhibition (binding) = 43 % Inhibition of human recombinant P-selectin expressed in CHO cells by Biacore assay at 1 mM ChEMBL. 17201408

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.